We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Malignant Glioma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00539344
Recruitment Status : Completed
First Posted : October 4, 2007
Last Update Posted : July 31, 2014
Sponsor:
Information provided by: